Innovating Works

NEWCELLS BIOTECH LIMITED

Desconocido
SCilS: Studying Ciliary Signaling in Development and Disease NEWCELLS BIOTECH LIMITED participó en un H2020 H2020-MSCA-ITN-2019 SCilS will create a multidisciplinary and intersectoral European training network focusing on ciliary signalling in development and disease....
2019-08-12 - 2024-06-30 | Financiado
StarT: European Training Network to Diagnose Understand and Treat Stargardt Disease a Frequent Inherited... NEWCELLS BIOTECH LIMITED participó en un H2020 H2020-MSCA-ITN-2018 StarT will create an interdisciplinary and intersectorial European training network focusing on different aspects of autosomal recessive Sta...
2018-08-30 - 2023-03-31 | Financiado
in3: An integrated interdisciplinary approach to animal free chemical and nanomaterial safety assessment NEWCELLS BIOTECH LIMITED participó en un H2020 H2020-MSCA-ITN-2016 All chemicals whether they are drugs, cosmetics, agrochemicals or others need to be tested for their safety to man and the environment. The...
2016-08-31 - 2021-06-30 | Financiado
STEMBANCC: Stem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC) NEWCELLS BIOTECH LIMITED participó en un FP6 StemBANCC, comprising internationally renowned investigators, is ideally positioned to deliver a unique European biorepository and drug disc...
2012-10-01 - 2018-03-31 | Financiado
STEMBANCC: Stem cells for Biological Assays of Novel drugs and prediCtive toxiCology StemBANCC NEWCELLS BIOTECH LIMITED participó en un FP7 StemBANCC, comprising internationally renowned investigators, is ideally positioned to deliver a unique European biorepository and drug disc...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.